Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 5/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10030733 | 0.94 | HPGD (0.47) | EPHX2HPGDCNR2SIRT2 | |
| SCHEMBL10030734 | 0.91 | THRB (0.50) | EPHX2HPGDCNR2TAAR1HDAC1 | |
| SCHEMBL10030730 | 0.91 | HPGD (0.54) | EPHX2HPGDCNR2FAAHLMNA | |
| SCHEMBL4570246 | 0.90 | DGKA (0.47) | EPHX2HPGDCNR2FAAH | |
| SCHEMBL12451260 | 0.90 | DGKA (0.47) | EPHX2HPGDCNR2FAAH | |
| SCHEMBL14370086 | 0.88 | DGKA (0.45) | EPHX2HPGDCNR2FAAH | |
| SCHEMBL10033435 | 0.88 | DGKA (0.49) | EPHX2HPGDFAAH | |
| SCHEMBL13324820 | 0.87 | DGKA (0.44) | EPHX2HPGDCNR2FAAH | |
| SCHEMBL10308812 | 0.87 | NAAA (0.44) | EPHX2HPGDCNR2FAAH | |
| SCHEMBL13324790 | 0.87 | DGKA (0.44) | EPHX2HPGDCNR2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9012527-B2 | Curable compositions for three-dimensional printing | XEROX CORPORATION (US) | 2015-04-21 | — | — | US | disclosed |
| US-9012527-B2 | Curable compositions for three-dimensional printing | XEROX CORPORATION (US) | 2015-04-21 | — | — | US | disclosed |
| US-20140053754-A1 | CURABLE COMPOSITIONS FOR THREE-DIMENSIONAL PRINTING | XEROX CORPORATION (US) | 2014-02-27 | — | — | US | disclosed |
| US-20140053754-A1 | CURABLE COMPOSITIONS FOR THREE-DIMENSIONAL PRINTING | XEROX CORPORATION (US) | 2014-02-27 | — | — | US | disclosed |
| US-8581000-B2 | Process for preparing amide gellant compounds with aromatic end groups | XEROX CORPORATION (US) | 2013-11-12 | — | — | US | disclosed |
| US-8507584-B2 | Phase change inks containing amide gellant compounds with aromatic end groups | XEROX CORPORATION (US) | 2013-08-13 | — | — | US | disclosed |
| US-8507584-B2 | Phase change inks containing amide gellant compounds with aromatic end groups | XEROX CORPORATION (US) | 2013-08-13 | — | — | US | disclosed |
| US-20120309924-A1 | Process for Preparing Amide Gellant Compounds with Aromatic End Groups | XEROX CORPORATION (US) | 2012-12-06 | — | — | US | disclosed |
| US-20120282448-A1 | METHODS FOR FABRICATING THREE-DIMENSIONAL OBJECTS | XEROX CORPORATION (US) | 2012-11-08 | — | — | US | disclosed |
| US-20120282448-A1 | METHODS FOR FABRICATING THREE-DIMENSIONAL OBJECTS | XEROX CORPORATION (US) | 2012-11-08 | — | — | US | disclosed |
| US-8084637-B2 | Amide gellant compounds with aromatic end groups | XEROX CORPORATION (US) | 2011-12-27 | — | — | US | disclosed |
| US-8084637-B2 | Amide gellant compounds with aromatic end groups | XEROX CORPORATION (US) | 2011-12-27 | — | — | US | disclosed |
| US-20110262711-A1 | CURABLE COMPOSITIONS FOR THREE-DIMENSIONAL PRINTING | XEROX CORPORATION (US) | 2011-10-27 | — | — | US | disclosed |
| US-20110263769-A1 | Phase Change Inks Containing Amide Gellant Compounds With Aromatic End Groups | XEROX CORPORATION (US) | 2011-10-27 | — | — | US | disclosed |
| US-20110263890-A1 | Amide Gellant Compounds With Aromatic End Groups | XEROX CORPORATION (US) | 2011-10-27 | — | — | US | disclosed |
| US-20110263769-A1 | Phase Change Inks Containing Amide Gellant Compounds With Aromatic End Groups | XEROX CORPORATION (US) | 2011-10-27 | — | — | US | disclosed |
| US-20110262711-A1 | CURABLE COMPOSITIONS FOR THREE-DIMENSIONAL PRINTING | XEROX CORPORATION (US) | 2011-10-27 | — | — | US | disclosed |
| US-20110263890-A1 | Amide Gellant Compounds With Aromatic End Groups | XEROX CORPORATION (US) | 2011-10-27 | — | — | US | disclosed |
| US-20110262643-A1 | INK COMPOSITIONS AND METHODS | XEROX CORPORATION (US) | 2011-10-27 | — | — | US | disclosed |
| US-20110262643-A1 | INK COMPOSITIONS AND METHODS | XEROX CORPORATION (US) | 2011-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263890-A1 | Amide Gellant Compounds With Aromatic End Groups | NAT1, AGPAT2, CCNT1 | EPHX2 1171/4885HPGD 3248/4885CNR2 56/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.